PRINCETON, N.J.— 2021 年 11 月 4 日 — Certara, Inc. （纳斯达克股票代码：CERT), a global leader in biosimulation, today announced that seven of the Company’s scientists have been featured in a list of the top 2% of scientists worldwide. The list was published on 2021 年 10 月 19 日 by Elsevier BV and Stanford University.
The ranking of scientists worldwide is based on a composite citation score or a percentile rank of 2% or above. Scientists are classified into 22 scientific fields and 176 sub-fields. The seven scientists at Certara, who were ranked on the list, were recognized in the fields of toxicology and pharmacology & pharmacy and a range of sub-fields, including endocrinology and metabolism, pediatrics, microbiology, chemistry, and medicinal and biomolecular.
“I would like to congratulate our scientific leaders not only for receiving this prestigious recognition but also for their significant contributions to pharmaceutical sciences and impact on drug development and ultimately patients,” said William F. Feehery, Ph.D., chief executive officer of Certara. “Science is at the foundation of what we do at Certara, and we have some of the world’s leading scientists working on the toughest challenges in drug development today.”
关于Certara
Certara利用生物模拟软件和技术加速药物开发，革新传统药物的发现和开发。Certara的客户覆盖全球1,650多家生物制药公司61个国家和地区的、领先学术机构和主要监管机构。
Certara 联系人：
Jieun Choe
Chief Strategy and Marketing Officer
jieun.choe@certara.com
